(Q43209378)

English

Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial

scientific article published on 22 July 2009

Statements

Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial (English)
Bimmer E Claessen
Marcel A Beijk
Victor Legrand
Antonio Manari
Olivier Varenne
Karine Miquel-Hebert
Susan Veldhof
Jose P S Henriques
Jan J Piek
22 July 2009
339-347

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit